{"nctId":"NCT00362648","briefTitle":"Developing World Study for RotaTeq™ (V260-015)(COMPLETED)","startDateStruct":{"date":"2007-03"},"conditions":["Vomiting","Diarrhea","Fever"],"count":7504,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Biological: RotaTeq™ - Rotavirus Vaccine, Live, Oral, Pentavalent"]},{"label":"2","type":"PLACEBO_COMPARATOR","interventionNames":["Biological: Comparator: Placebo"]}],"interventions":[{"name":"RotaTeq™ - Rotavirus Vaccine, Live, Oral, Pentavalent","otherNames":["RotaTeq™","V260"]},{"name":"Comparator: Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 4 weeks through 12 weeks at Dose 1\n* Parent able to understand study procedures and give consent\n\nExclusion Criteria:\n\n* Clinical evidence of active gastrointestinal disease\n* Subjects who are currently or expected to participate in other studies of investigational products during the 6 weeks after receiving the last dose of RotaTeq™/placebo","healthyVolunteers":true,"sex":"ALL","minimumAge":"4 Weeks","maximumAge":"12 Weeks","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Occurrence of Severe Clinical Rotavirus Disease Caused by Any Rotavirus Serotype More Than 14 Days Following the Third Dose","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"79","spread":null},{"groupId":"OG001","value":"129","spread":null},{"groupId":"OG002","value":"38","spread":null},{"groupId":"OG003","value":"71","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2278","spread":null},{"groupId":"OG001","value":"2219","spread":null},{"groupId":"OG002","value":"953","spread":null},{"groupId":"OG003","value":"907","spread":null}]}]}]},{"type":"SECONDARY","title":"Africa - Serum Anti-rotavirus IgA Responses and Serum Neutralizing Antibody (SNA) Responses Against Rotavirus Serotypes G1, G2, G3, G4, and P1A[8]","description":"Induction of postdose 3 SNA response (Number of subjects with ≥ 3 fold rise in antibody titer)","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"148","spread":null},{"groupId":"OG001","value":"34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"35","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"50","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"Asia - Serum Anti-rotavirus IgA Responses and Serum Neutralizing Antibody (SNA) Responses Against Rotavirus Serotypes G1, G2, G3, G4, and P1A[8]","description":"Induction of postdose 3 SNA response (Number of subjects with ≥ 3 fold rise in antibody titer)","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"115","spread":null},{"groupId":"OG001","value":"24","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"36","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":144,"n":3744},"commonTop":["Pyrexia","Cough","Diarrhoea","Rhinitis","Rash"]}}}